Ethylphenidate
Top View
- Dexmethylphenidate Hydrochloride Tablets)
- Absorption Differences Between Immediate-Release Dexmethylphenidate and Dl-Methylphenidate
- Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS)
- Pharmacological Profile of Methylphenidate-Based Designer Drugs
- Substance Abuse in the Workplaces of Our Bodies and Mind
- 2020 Controlled Substance List
- WHO Expert Committee on Drug Dependence (ECDD)
- In Vitro Neurochemical Assessment of Methylphenidate and Its ``Legal
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- Characterization of Influx Transporters in the Blood-Brain Barrier: Implications for Drug Delivery
- Ethylphenidate (EPH) Critical Review Report Agenda Item 4.7
- Temporary Class Drug Order (TCDO)
- Ethylphenidate: from Biomarker to Designer Drug John S
- Current P SYCHIATRY Visit the All-New Currentpsychiatry.Com
- (12) Patent Application Publication (10) Pub. No.: US 2012/0245201 A1 Markowitz Et Al
- Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
- Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects
- Comparative Efficacy, Acceptability, and Tolerability Of